Market Place
Market Place
Post Enquiry
Enforcement Report - Week of October 9, 2024
09 Oct 2024 //
FDA
FDA Issues Form 483 to Nanchang Anobri Pharmaceutical Co.
08 Oct 2024 //
FDA
FDA Issues Form 483 to Aqualex Co., Ltd.
08 Oct 2024 //
FDA
FDA Issues Form 483 to Apitoria Pharma Private Ltd.
07 Oct 2024 //
FDA
FDA Issues Form 483 to Biocon Sdn.
07 Oct 2024 //
FDA
Enforcement Report - Week of October 2, 2024
02 Oct 2024 //
FDA
Makra Kozmetika Receives FDA Warning Letter
01 Oct 2024 //
FDA
Clean Solutions Receives FDA Warning Letter
01 Oct 2024 //
FDA
Aerosol and Liquid Packaging Receives FDA Warning Letter
01 Oct 2024 //
FDA
Originitalia is on FDA Import Alert List
01 Oct 2024 //
FDA
Diamond Chemical Co. Receives FDA Warning Letter
01 Oct 2024 //
FDA
MMC Healthcare Ltd. Receives FDA Warning Letter
01 Oct 2024 //
FDA
FDA Issues Form 483 to Terumo Yamaguchi Corp.
25 Sep 2024 //
FDA
FDA Issues Form 483 to Samsung Bioepis Co., Ltd.
25 Sep 2024 //
FDA
Aerosol and Liquid Packaging, Inc. Receives FDA Warning Letter
24 Sep 2024 //
FDA
Accupack Midwest, Inc. Receives FDA Warning Letter
24 Sep 2024 //
FDA
Wittman Pharma, Inc. Receives FDA Warning Letter
24 Sep 2024 //
FDA
FDA Issues Form 483 to Takeda Pharmaceutical Company Limited
24 Sep 2024 //
FDA
FDA Issues Form 483 to Eisai
24 Sep 2024 //
FDA
Gilead Issues Voluntary Nationwide Recall of One Lot of Veklury
23 Sep 2024 //
FDA
FDA Issues Form 483 to First Cah Co., Ltd.
23 Sep 2024 //
FDA
FDA Issues Form 483 to Hugel, Inc.
23 Sep 2024 //
FDA
123Herbals Issues Voluntary Nationwide Recall of Vail-Bon
20 Sep 2024 //
FDA
FDA Issues Form 483 to C&T Dream Co.
20 Sep 2024 //
FDA
Enforcement Report - Week of September 18, 2024
18 Sep 2024 //
FDA
Bionpharma Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension
18 Sep 2024 //
FDA
TJA Health, LLC Receives FDA Warning Letter
17 Sep 2024 //
FDA
Greco Gas, Inc. Receives FDA Warning Letter
17 Sep 2024 //
FDA
FDA Issues Form 483 to Industria Farmaceutica Nova Argentia
17 Sep 2024 //
FDA
FDA Issues Form 483 to Gland Pharma
17 Sep 2024 //
FDA
Enforcement Report - Week of September 11, 2024
11 Sep 2024 //
FDA
Menadiona Fails EDQM inspection
11 Sep 2024 //
EMA
Zydus Lifesciences Receives FDA Warning Letter
10 Sep 2024 //
FDA
Orean Personal Care Ltd. Receives FDA Warning Letter
10 Sep 2024 //
FDA
Avaria Health & Beauty Corp. Receives FDA Warning Letter
10 Sep 2024 //
FDA
Regenerative Processing Plant, LLC Receives FDA Warning Letter
06 Sep 2024 //
FDA
FDA Issues Form 483 to Biocon Biologics Limited
06 Sep 2024 //
FDA
FDA Issues Form 483 to Taenaka Kogyo Co., Ltd.
06 Sep 2024 //
FDA
Enforcement Report - Week of September 4, 2024
04 Sep 2024 //
FDA
Kaylaan LLC Receives FDA Warning Letter
03 Sep 2024 //
FDA
FDA Issues Form 483 to Otsuka Pharmaceutical Co.
30 Aug 2024 //
FDA
Enforcement Report - Week of August 28, 2024
28 Aug 2024 //
FDA
FDA Issues Form 483 to Global Calcium Private
28 Aug 2024 //
FDA
EyePoint Pharmaceuticals Receives FDA Warning Letter
27 Aug 2024 //
FDA
CARsgen Therapeutics Receives FDA Warning Letter
27 Aug 2024 //
FDA
Berkeley Biologics Receives FDA Warning Letter
27 Aug 2024 //
FDA
Eugia Pharma Specialities Receives FDA Warning Letter
21 Aug 2024 //
FDA
Intercos Europe Receives FDA Warning Letter
21 Aug 2024 //
FDA
Enforcement Report - Week of August 21, 2024
21 Aug 2024 //
FDA
Veata Issues Voluntary Nationwide Recall of Endurance Sildenafil
21 Aug 2024 //
FDA
Boulla Issues Voluntary Nationwide Recall For Sildenafil
21 Aug 2024 //
FDA
Anhui Bayi Chemical Industry Fails EDQM inspection
16 Aug 2024 //
EDQM
Nowrez & Ismail Shukri Company Receives FDA Warning Letter
13 Aug 2024 //
FDA
LS Promotions Receives FDA Warning Letter
13 Aug 2024 //
FDA
FDA Issues Form 483 to Nubratori
08 Aug 2024 //
FDA
Enforcement Report for Week of August 7, 2024
07 Aug 2024 //
FDA
Velocity Pharma Receives FDA Warning Letter
06 Aug 2024 //
FDA
Velocity Pharma Receives FDA Warning Letter
06 Aug 2024 //
FDA
Guangzhou Baiyunshan Jingxiutang Pharmaceutical Receives FDA Warning Letter
06 Aug 2024 //
FDA
